| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |